Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has issued an update.
China Resources Pharmaceutical Group Ltd. has announced proposed amendments to its Articles of Association, aiming to align with the latest legal and regulatory requirements concerning treasury shares and shareholder communication. These changes are subject to shareholder approval at an upcoming extraordinary general meeting, reflecting the company’s commitment to compliance and operational transparency.
The most recent analyst rating on (HK:3320) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, focusing on aligning with legal and regulatory standards in its market.
Average Trading Volume: 16,552,619
Technical Sentiment Signal: Sell
Current Market Cap: HK$30.28B
See more insights into 3320 stock on TipRanks’ Stock Analysis page.